|
|
Other links at Articles > Family Medicine |
| 4. |
No Cancer Risk Elevation From ARBs: Two New Analyses
|
|
|
A new cohort study and a meta-analysis join previous reports in refuting a controversial finding from last year that treatment with angiotensin-receptor blockers may elevate the risk of cancer, especially lung cancer. Heartwire
|
|
|